Navigation Links
Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller
Date:4/10/2009

ST. LOUIS, April 10 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce the appointment of Michael Kanan as Vice President and Corporate Controller effective April 13, 2009. Kanan (age 46) succeeds Karen Miller who was recently promoted to Vice President-Strategy & Corporate Development. He will report to Rakesh Sachdev, Vice President and Chief Financial Officer (CFO).

Kanan brings two decades of financial experience in assignments of increasing responsibility with him to Sigma-Aldrich. His most recent position at ArvinMeritor, a $7 billion Fortune 500 global manufacturer of commercial and light vehicle systems, was Vice President Finance-Light Vehicle Systems since 2006. His prior experience at ArvinMeritor includes five years as Vice President and Assistant Corporate Controller. Kanan also spent five years with Hutchinson Group N. America, a subsidiary of Total SA, after beginning his career in with Deloitte & Touche in the mid 1980s.

He holds a Bachelor of Arts degree in Accounting from Michigan State University and became a CPA in 1987. Mike, his wife Sharon, and their two children will be relocating to St. Louis where he will be based at Sigma-Aldrich's corporate headquarters.

Vice President and Chief Financial Officer Rakesh Sachdev commented, "We are excited to welcome Mike to Sigma-Aldrich. His experience in leading a global finance operation can only further enhance our own leadership position in our industry. Mike has established an impressive track record of success, demonstrating strong leadership, innovative thinking and operational excellence. I'm excited to work closely with him as we execute our strategy for driving growth across our businesses and further building shareholder value."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sigma-Aldrich Enters Distribution Agreement With AlphaGenix, Inc.
2. Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
3. Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend
4. Sigma-Aldrich Amends Credit Facility and Expands Commercial Paper Program
5. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
6. Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification
7. Spectrum Surgical Instruments Announces: Quality Management System Certification
8. Sutter Health Announces 2008 Financial Performance
9. Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008
10. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
11. Burrill & Company Announces Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed ... stem cell therapy technology, protocols and patient results as have been achieved with ... a more accessible standard of care for patients worldwide. , As the Medical Advisory ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of experience, ... job, ensuring the best suited solution to meet regulatory requirements. Their professional staff ... lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is ... leader in the development of technological innovations that lead to broad-based healthcare solutions. ...
(Date:5/24/2016)... ... May 24, 2016 , ... WaterAid launched the #perioddrama campaign to mark ... than 1 billion women around the world who do not have access to a toilet, ... the US about their dread of #perioddrama. The (sometimes hilarious) results help shine a light ...
(Date:5/24/2016)... ... May 24, 2016 , ... Aloria ... Services To Begin In June , Aloria Health, specializing in a re-imagined, client-oriented ... of Aloria Milwaukee, its first treatment facility for outpatient, day treatment and residential ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... World Health Organization (WHO) expanded the Intended Use of the ... years, and above. Effective immediately, the PrePex device, manufactured by ... in the 14 priority countries in Southern and ... device to receive WHO Prequalification on 31 May 2013. ... The expanded use of PrePex for younger ages ...
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
Breaking Medicine Technology: